Today

Agents

Chat

Arena

Discover

More

App

Wave Life Sciences Ltd.: Canaccord Genuity raises target price to $44 from $42 - WVE News | Rallies

Wave Life Sciences Ltd.: Canaccord Genuity raises target price to $44 from $42

WVE•2026-10-28

Canaccord Genuity raised its target price for Wave Life Sciences to $44 from $42.

Related News

Del Monte forecasts 2026 adjusted EBITDA of $230 million-$240 million

FDP•2026-10-28

Werner Enterprises target price cut to $34 from $39 by TD Cowen

WERN•2026-10-28

New UK finance minister unveils 'steady as you go' budget

EWU•2026-10-28

Highwoods Properties raises 2026 FFO outlook to $3.51-$3.70 a share

HIW•2026-10-28

Stray alert tagged to CAE Inc and Air Canada withdrawn

CAE•2026-10-28